(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.
Mark L. Fuerst
Recent studies address two of the most troubling symptoms of fibromyalgia: pain and cognitive impairment.
What’s new: (1) Gut bacterium may trigger autoimmune disease; (2) pregnancy complications in SLE have declined; (3) childhood abuse raises lupus risk.
(1) Exercise limits bone loss but not weight gain; (2) BMD may serve as a biomarker; (3) men are at high risk for secondary fractures.
What’s new: biologic tapering, high-dose influenza vaccine, real-time patient input.
What’s new: cannabinoids, mindfulness, and the depression-arthritis connection.
(1) Menopause worsens RA symptoms; (2) obesity increases disease activity in women with lupus; and (3) signs of cardiac disease appear early in SLE.
(1) Questionable efficacy of knee injections, (2) a dramatic increase in the prevalence of osteoarthritis, and (3) a promising molecular biomarker.
Here: the impact of vitamin D, the Mediterranean diet, and psychological stress on disease severity.
Similarities between ankylosing spondylitis and non-radiographic axial SpA, a caveat about positive MRI scans, and the impact of obesity on disease outcomes.